Items where Author is "Yerly, S."

2013

Cusini, A. and Vernazza, P. L. and Yerly, S. and Decosterd, L. A. and Ledergerber, B. and Fux, C. A. and Rohrbach, J. and Widmer, N. and Hirschel, B. and Gaudenz, R. and Cavassini, M. and Klimkait, T. and Zenger, F. and Gutmann, C. and Opravil, M. and Gunthard, H. F. and Swiss HIV Cohort Study, . (2013) Higher CNS Penetration-Effectiveness of Long-term Combination Antiretroviral Therapy Is Associated With Better HIV-1 Viral Suppression in Cerebrospinal Fluid. JAIDS: journal of acquired immune deficiency syndromes, Vol. 62, H. 1. pp. 28-35.

Schupbach, J. and Gebhardt, M. D. and Scherrer, A. U. and Bisset, L. R. and Niederhauser, C. and Regenass, S. and Yerly, S. and Aubert, V. and Suter, F. and Pfister, S. and Martinetti, G. and Andreutti, C. and Klimkait, T. and Brandenberger, M. and Gunthard, H. F. and Swiss HIV Cohort Study, . (2013) Simple Estimation of Incident HIV Infection Rates in Notification Cohorts Based on Window Periods of Algorithms for Evaluation of Line-Immunoassay Result Patterns. PLoS one, Vol. 8, H. 8 , e71662.

Beerenwinkel, N. and Montazeri, H. and Schuhmacher, H. and Knupfer, P. and von Wyl, V. and Furrer, H. and Battegay, M. and Hirschel, B. and Cavassini, M. and Vernazza, P. and Bernasconi, E. and Yerly, S. and Boni, J. and Klimkait, T. and Cellerai, C. and Gunthard, H. F. and Swiss HIV Cohort Study, . (2013) The Individualized Genetic Barrier Predicts Treatment Response in a Large Cohort of HIV-1 Infected Patients. PLoS Computational Biology, Vol. 9, H. 8 , e1003203.

2012

Schupbach, J. and Bisset, L. R. and Gebhardt, M. D. and Regenass, S. and Burgisser, P. and Gorgievski, M. and Klimkait, T. and Andreutti, C. and Martinetti, G. and Niederhauser, C. and Yerly, S. and Pfister, S. and Schultze, D. and Brandenberger, M. and Schoni-Affolter, F. and Scherrer, A. U. and Gunthard, H. F. and Swiss HIV Cohort Study, . (2012) Diagnostic performance of line-immunoassay based algorithms for incident HIV-1 infection. BMC infectious diseases, Vol. 12 , 88.

Stadler, T. and Kouyos, R. and von Wyl, V. and Yerly, S. and Boni, J. and Burgisser, P. and Klimkait, T. and Joos, B. and Rieder, P. and Xie, D. and Gunthard, H. F. and Drummond, A. J. and Bonhoeffer, S. and Swiss HIV Cohort Study, . (2012) Estimating the basic reproductive number from viral sequence data. Molecular biology and evolution, Vol. 29, no 1. pp. 347-357.

Leventhal, G. E. and Kouyos, R. and Stadler, T. and von Wyl, V. and Yerly, S. and Boni, J. and Cellerai, C. and Klimkait, T. and Gunthard, H. F. and Bonhoeffer, S.. (2012) Inferring epidemic contact structure from phylogenetic trees. PLoS Computational Biology, Vol. 8, H. 3 , e1002413.

Scherrer, A. U. and Boni, J. and Yerly, S. and Klimkait, T. and Aubert, V. and Furrer, H. and Calmy, A. and Cavassini, M. and Elzi, L. and Vernazza, P. L. and Bernasconi, E. and Ledergerber, B. and Gunthard, H. F. and Swiss HIV Cohort Study Shcs, . (2012) Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens. PLoS one, Vol. 7, H. 11 , e50307.

Scherrer, A. U. and Ledergerber, B. and von Wyl, V. and Boni, J. and Yerly, S. and Klimkait, T. and Cellerai, C. and Furrer, H. and Calmy, A. and Cavassini, M. and Elzi, L. and Vernazza, P. L. and Bernasconi, E. and Gunthard, H. F. and Swiss HIV Cohort Study Shcs, . (2012) Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients. PLoS one, Vol. 7, H. 6 , e37983.

Scherrer, A. U. and von Wyl, V. and Gotte, M. and Klimkait, T. and Cellerai, C. and Yerly, S. and Boni, J. and Held, L. and Ledergerber, B. and Gunthard, H. F. and Swiss HIV Cohort Study, . (2012) Polymorphic mutations associated with the emergence of the multinucleoside/tide resistance mutations 69 insertion and Q151M. Journal of acquired immune deficiency syndromes and human retrovirology, Vol. 59, H. 2. pp. 105-112.

2011

Kouyos, R. D. and von Wyl, V. and Yerly, S. and Boni, J. and Rieder, P. and Joos, B. and Taffe, P. and Shah, C. and Burgisser, P. and Klimkait, T. and Weber, R. and Hirschel, B. and Cavassini, M. and Rauch, A. and Battegay, M. and Vernazza, P. L. and Bernasconi, E. and Ledergerber, B. and Bonhoeffer, S. and Gunthard, H. F. and Swiss HIV Cohort Study, . (2011) Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection. Clinical Infectious Diseases, Vol. 52, H. 4. pp. 532-539.

Kouyos, R. D. and von Wyl, V. and Hinkley, T. and Petropoulos, C. J. and Haddad, M. and Whitcomb, J. M. and Boni, J. and Yerly, S. and Cellerai, C. and Klimkait, T. and Gunthard, H. F. and Bonhoeffer, S. and Swiss HIV Cohort Study, . (2011) Assessing predicted HIV-1 replicative capacity in a clinical setting. PLoS Pathogens, Vol. 7, H. 11 , e1002321.

El Amari, E. Boffi and Combescure, C. and Yerly, S. and Calmy, A. and Kaiser, L. and Hasse, B. and Furrer, H. and Cavassini, M. and Vernazza, P. and Hirsch, Hh and Bernasconi, E. and Hirschel, B. and Swiss HIV Cohort Study, . (2011) Clinical relevance of cytomegalovirus viraemia(*,†). HIV medicine, Vol. 12, H. 7. pp. 394-402.

Young, J. and Scherrer, A. U. and Günthard, H. F. and Opravil, M. and Yerly, S. and Böni, J. and Rickenbach, M. and Fux, C. A. and Cavassini, M. and Bernasconi, E. and Vernazza, P. and Hirschel, B. and Battegay, M. and Bucher, H. C. and Swiss HIV Cohort Study, . (2011) Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients : the Swiss HIV Cohort Study. HIV medicine, Vol. 12, H. 5. pp. 299-307.

Schüpbach, Jörg and Bisset, Leslie R. and Regenass, Stephan and Bürgisser, Philippe and Gorgievski, Meri and Steffen, Ingrid and Andreutti, Corinne and Martinetti, Gladys and Shah, Cyril and Yerly, Sabine and Klimkait, Thomas and Gebhardt, Martin and Schöni-Affolter, Franziska and Rickenbach, Martin and Swiss HIV Cohort Study, and Barth, J. and Battegay, M. and Bernascon, E. and Böni, J. and Bucher, H. C. and Bürgisser, P. and Burton-Jeangros, C. and Calmy, A. and Cavassini, M. and Dubs, R. and Egger, M. and Elzi, L. and Fehr, J. and Fischer, M. and Flepp, M. and Francioli, P. and Furrer, H. and Fux, C. A. and Gorgievski, M. and Günthard, H. and Hasse, B. and Hirsch, H. H. and Hirschel, B. and Hösli, I. and Kahlert, C. and Kaiser, L. and Keiser, O. and Kind, C. and Klimkait, T. and Kovari, H. and Ledergerber, B. and Martinetti, G. and Martinez de Tejada, B. and Müller, N. and Nadal, D. and Pantaleo, G. and Rauch, A. and Regenass, S. and Rickenbach, M. and Rudin, C. and Schmid, P. and Schultze, D. and Schöni-Affolter, F. and Schüpbach, J. and Speck, R. and Taffé, P. and Telenti, A. and Trkola, A. and Vernazza, P. and von Wyl, V. and Weber, R. and Yerly, S.. (2011) High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease. BMC infectious diseases, Vol. 11 , 254. p. 254.

Scherrer, A. U. and von Wyl, V. and Joos, B. and Klimkait, T. and Burgisser, P. and Yerly, S. and Boni, J. and Ledergerber, B. and Gunthard, H. F. and Swiss HIV Cohort Study, . (2011) Predictors for the emergence of the 2 multi-nucleoside/nucleotide resistance mutations 69 insertion and Q151M and their impact on clinical outcome in the Swiss HIV cohort study. Journal of Infectious Diseases, Vol. 203, no. 6. pp. 791-797.

Fehr, J. and Glass, T. R. and Louvel, S. and Hamy, F. and Hirsch, H. H. and von Wyl, V. and Boni, J. and Yerly, S. and Burgisser, P. and Cavassini, M. and Fux, C. A. and Hirschel, B. and Vernazza, P. and Martinetti, G. and Bernasconi, E. and Gunthard, H. F. and Battegay, M. and Bucher, H. C. and Klimkait, T.. (2011) Replicative phenotyping adds value to genotypic resistance testing in heavily pre-treated HIV-infected individuals - the Swiss HIV Cohort Study. Journal of translational medicine, Vol. 9 , 14. p. 14.

Scherrer, A. U. and von Wyl, V. and Boni, J. and Yerly, S. and Klimkait, T. and Burgisser, P. and Garzoni, C. and Hirschel, B. and Cavassini, M. and Battegay, M. and Vernazza, P. L. and Bernasconi, E. and Ledergerber, B. and Gunthard, H. F. and Swiss HIV Cohort Study Shcs, . (2011) Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors. JAIDS, Vol. 57, H. 1. pp. 24-31.

2010

Kouyos, R. D. and von Wyl, V. and Yerly, S. and Boni, J. and Rieder, P. and Joos, B. and Taffe, P. and Shah, C. and Burgisser, P. and Klimkait, T. and Weber, R. and Hirschel, B. and Cavassini, M. and Rauch, A. and Battegay, M. and Vernazza, P. L. and Bernasconi, E. and Ledergerber, B. and Bonhoeffer, S. and Gunthard, H. F. and Swiss HIV Cohort Study, . (2010) Ambiguity in population-based sequencing of HIV-1 as a marker for the age of HIV infection. Antiviral therapy, Vol. 15 , A158-A158.

2009

Scherrer, A. U. and Hasse, B. and von Wyl, V. and Yerly, S. and Böni, J. and Bürgisser, P. and Klimkait, T. and Bucher, H. C. and Ledergerber, B. and Günthard, H. F.. (2009) Prevalence of etravirine mutations and impact on response to treatment in routine clinical care : the Swiss HIV Cohort Study (SHCS). HIV medicine : the official journal of the British HIV Association (BHIVA) and the European AIDS Clinical Society (EACS), Vol. 10. pp. 647-656.

2008

von Wyl, V. and Yerly, S. and Böni, J. and Bürgisser, P. and Klimkait, T. and Battegay, M. and Bernasconi, E. and Cavassini, M. and Furrer, H. and Hirschel, B. and Vernazza, P. L. and Rickenbach, M. and Ledergerber, B. and Günthard, H. F. and Swiss, HIV Cohort Study. (2008) Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir. Clinical Infectious Diseases, Vol. 46. pp. 1299-1309.